Docosanol Patent Expiration
Docosanol is Used for treating cold sores and fever blisters on the face or lips by shortening healing time and reducing symptoms. It was first introduced by Haleon Us Holdings Llc
Docosanol Patents
Given below is the list of patents protecting Docosanol, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Abreva | US4874794 | Inflammatory disease treatment |
Apr 28, 2014
(Expired) | Haleon Us Holdings |
| Abreva | US5534554 | Sucrose ester-C20 to C28 alcohol formulations |
Dec 13, 2013
(Expired) | Haleon Us Holdings |
Docosanol's Family Patents
Explore Our Curated Drug Screens
Docosanol Generic API Manufacturers
Several generic applications have been filed for Docosanol. The first generic version for Docosanol was by P And L Development Llc and was approved on Nov 19, 2018. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Mar 1, 2024.
Given below is the list of companies who have filed for Docosanol generic, along with the locations of their manufacturing plants worldwide.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Docosanol. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10% | cream | Over the counter | TOPICAL | N/A | May 3, 2022 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
2. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 1 generic for Docosanol. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10% | cream | Over the counter | TOPICAL | N/A | Mar 1, 2024 |
Manufacturing Plant Locations New
Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| India |
| |||
3. P AND L
P And L Development Llc has filed for 1 generic for Docosanol. Given below are the details of the strengths of this generic introduced by P And L.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10% | cream | Over the counter | TOPICAL | N/A | Nov 19, 2018 |
4. P AND L DEVELOPMENT
P And L Development Llc has filed for 1 generic for Docosanol. Given below are the details of the strengths of this generic introduced by P And L Development.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10% | cream | Over the counter | TOPICAL | N/A | Oct 7, 2022 |
5. TARO
Taro Pharmaceuticals Inc has filed for 1 generic for Docosanol. Given below are the details of the strengths of this generic introduced by Taro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10% | cream | Over the counter | TOPICAL | N/A | Oct 26, 2023 |
Manufacturing Plant Locations New
Taro's manufacturing plants are situated in 3 countries - United States, Israel, Canada. Given below are the details of these plant locations as well as the firm names of Taro as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| Israel |
| |||||
| Canada |
| |||||